First Patient Dosed in Clinical Study of TLX250-CDx in Bladder Cancer
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/5/2026
- Nasdaq notches record high close as investors focus on earnings
- Oil slips on rising Mideast crude exports, G7 stocks release
- Intel stock slides as TSMC explores Terafab tie-up, analyst flags share losses
- Schneider Electric to acquire PTC for $22.6 billion in all-cash deal
- Five things to watch in markets in the week ahead
| TRANS-LUX CORPORATION (NASDAQ: TLX) | Delayed: 10.88 +0.33 (3.13%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $10.55 | 52 Week High | $2.18 | |||
| Open | $10.80 | 52 Week Low | $0.30 | |||
| Day High | $10.91 | P/E | N/A | |||
| Day Low | $10.79 | EPS | $-3.32 | |||
| Volume | 235,273 | |||||
